Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Cancer Research|November 9, 2016
PROTOCADHERIN 7 Acts through SET and PP2A to Potentiate MAPK Signaling by EGFR and KRAS during Lung TumorigenesisXiaorong Zhou, Barrett L Updegraff, Yabin Guo, et al.
Journal of the National Cancer Institute|April 5, 2017
Role of CPS1 in Cell Growth, Metabolism and Prognosis in LKB1-Inactivated Lung AdenocarcinomaMüge Çeliktas, Ichidai Tanaka, Satyendra Chandra Tripathi, et al.
Molecular Cancer Therapeutics|July 31, 2019
Tyrosine Threonine Kinase Inhibition Eliminates Lung Cancers by Augmenting Apoptosis and PolyploidyLin Zheng, Zibo Chen, Masanori Kawakami, et al.
Scientific Reports|July 27, 2017
Thy-1+ Cancer-associated Fibroblasts Adversely Impact Lung Cancer PrognosisMark J Schliekelman, Chad J Creighton, Brandi N Baird, et al.
Frontiers in Oncology|April 10, 2023
Glucocorticoid mediated inhibition of LKB1 mutant non-small cell lung cancersKenneth E Huffman, Long Shan Li, Ryan Carstens, et al.
Nature|September 30, 2016
XPO1-dependent nuclear export is a druggable vulnerability in KRAS-mutant lung cancerJimi Kim, Elizabeth McMillan, Hyun Seok Kim, et al.
Oncotarget|October 20, 2018
Concomitant targeting of the mTOR/MAPK pathways: novel therapeutic strategy in subsets of RICTOR/KRAS-altered non-small cell lung cancerDennis Ruder, Vassiliki Papadimitrakopoulou, Kazuhiko Shien, et al.
Pageof 3